Interferon-γ release assay tests to rule out active tuberculosis [8]

European Respiratory Journal

Volumn 30, Issue 1, 2007, Pages 184-185

  van Leeuwen, R M ^a   Bossink, A W J ^a   Thijsen, S F T ^a  

^a DEPARTMENT OF SURGERY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; STEROID;

ACID FAST BACTERIUM; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; IMMUNOASSAY; INFECTION RISK; INTERFERON GAMMA RELEASE ASSAY TEST; LETTER; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 34447540235     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00051507     Document Type: Letter

References (5)

1. Ivan Leeuwen RM, Bossink AW, Thijsen SF. Exclusion of active Mycobacterium tuberculosis complex infection with the T-SPOT. TB assay. Eur Respir J 2007; 29: 605-607.
2. Dijkstra F, van Gageldonk-Lafeber AB, Brandsema P, et al. Respiratoire infectieziekten in het jaar 2005/2006. [Respiratory infections in the year 2005/2006.] Infectieziekten Bulletin 2006; 11: 390-397.
3. Hays WL. Statistics. 5th Edn. Oxford, Harcourt Brace College Publishers, 1994.
4. Ferrara G, Losi M, D'Amico R, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006; 367: 1328-1334.
5. Richeldi L, Ewer K, Losi M, et al. Early diagnosis of subclinical multidrug-resistant tuberculosis. Ann Intern Med 2004; 140: 709-713.